Qube Research & Technologies (QRT)
GRCL

Qube Research & Technologies (QRT)’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-517,274
Closed -$5.19M – 5005
2023
Q4 		$5.19M Buy
517,274
+514,647
+19,591% +$2.34M 0.01% 1018
2023
Q3 		$7.57K Buy
+2,627
New +$9.6K ﹤0.01% 3373
2022
Q1 		– Sell
-13,054
Closed -$79K – 3154
2021
Q4 		$79K Buy
+13,054
New +$126K ﹤0.01% 2190

Qube Research & Technologies (QRT)'s GRCL Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 517,274 shares — an estimated $5.19M sold.

Qube Research & Technologies (QRT) first reported a position in GRCL in Q4 2021 and held it in 3 quarters. The position peaked at $5.19M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 517,274 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $5.19M.
  • Qube Research & Technologies (QRT) first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Gracell Biotechnologies Inc. American Depositary Shares position peaked at $5.19M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.